Table 3.
Characterization of add-on VA therapy.
| VA Remedy | Total | Colorectal Cancer | Lung Cancer | Breast Cancer | Other Cancer |
|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | n (%) | |
| VA | 184 | 49 (100) | 40 (100) | 50 (100) | 45 (100) |
| VA abietis | 4 (2.1) | - | 1 (2.0) | 3 (6.0) | - |
| VA aceris | 6 (3.2) | - | 5 (10.2) | - | 1 (2.2) |
| VA craetegi | 2 (1.1) | 1 (2.0) | - | - | 1 (2.2) |
| VA fraxini | 119 (63.6) | 23 (46.9) | 32 (65.3) | 31 (62.0) | 34 (75.6) |
| VA mali | 20 (10.7) | 2 (4.1) | 1 (2.0) | 16 (32.0) | 1 (2.2) |
| VA quercus | 33 (17.6) | 27 (55.1) | 2 (4.1) | - | 4 (8.9) |
| VA pini | 6 (3.2) | 1 (2.0) | 1 (2.0) | 3 (6.0) | 1 (2.2) |
Characterization of add-on VA remedies in accordance to their respective host trees. Numbers in rows and columns do not necessarily add to 100%, as patients may have received various combinations of treatment. n, number; %, percent; -, not applicable.